Yiming Li

747 total citations
33 papers, 512 citations indexed

About

Yiming Li is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Yiming Li has authored 33 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 15 papers in Immunology and 9 papers in Molecular Biology. Recurrent topics in Yiming Li's work include Cancer Immunotherapy and Biomarkers (11 papers), Immunotherapy and Immune Responses (9 papers) and CAR-T cell therapy research (7 papers). Yiming Li is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Immunotherapy and Immune Responses (9 papers) and CAR-T cell therapy research (7 papers). Yiming Li collaborates with scholars based in China, United States and Vietnam. Yiming Li's co-authors include Zhi‐Nan Chen, Juan Tang, Jingmin Yu, Jian‐Li Jiang, Zhenyu Liu, Jianchao Wang, Rui He, Gang Cao, Qingyong Ma and Wen‐Bin Yang and has published in prestigious journals such as Hepatology, International Journal of Molecular Sciences and Construction and Building Materials.

In The Last Decade

Yiming Li

31 papers receiving 505 citations

Peers

Yiming Li

ONCOL

IMMUN

PRM

Dmitrij Ostroumov Germany

Daffyd Thomas United States

Shannon Zhang United States

Sabrina Carpentier France

Charlene M. Fares United States

Arnold Baars Netherlands

Priyanka B. Subrahmanyam United States

Lucia Musacchio Italy

Neil Gildener‐Leapman United States

Dmitrij Ostroumov Germany

Yiming Li

337 ×1.1

ONCOL

294 ×1.4

IMMUN

137 ×0.8

63 ×0.7

60 ×0.6

PRM

Citations per year, relative to Yiming Li Yiming Li (= 1×) peers Dmitrij Ostroumov

Countries citing papers authored by Yiming Li

Since Specialization

Citations

This map shows the geographic impact of Yiming Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiming Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiming Li more than expected).

Fields of papers citing papers by Yiming Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiming Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiming Li. The network helps show where Yiming Li may publish in the future.

Co-authorship network of co-authors of Yiming Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yiming Li. A scholar is included among the top collaborators of Yiming Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiming Li. Yiming Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guo, Feng, et al.. (2025). Assessing the mechanical properties, frost resistance, and microstructure of steel slag powder incorporated roadbeds foamed concrete. Construction and Building Materials. 502. 144452–144452.

Ma, Yifei, Yiwei Xu, Nianqi Liu, et al.. (2024). Cerebral¹⁸F-FDG PET/CT Metabolism as Diagnostic Signature for Central Nervous System Toxicity After Immune Checkpoint Blockade Cancer Treatment. Journal of Nuclear Medicine. 65(7). 1129–1136.

Zhang, Na, Yiming Li, Simin Guo, et al.. (2024). Isovalerylspiramycin I alleviates liver injury and liver fibrosis by targeting the nucleotide-binding protein 2 (NUBP2)-vascular non-inflammatory molecule-1 (VNN1) pathway. Journal of Pharmaceutical Analysis. 15(3). 101048–101048. 2 indexed citations

Zhang, Jing, Fang Liu, Ziyi Wu, et al.. (2024). ACETATE RINGER'S SOLUTION VERSUS NORMAL SALINE SOLUTION IN SEPSIS: A RANDOMIZED, CONTROLLED TRIAL. Shock. 61(4). 520–526. 2 indexed citations

Li, Yiming, Wenbin Zhao, Ying Shen, et al.. (2024). T Cell Receptor-Directed Bispecific T Cell Engager Targeting MHC-Linked NY-ESO-1 for Tumor Immunotherapy. Biomedicines. 12(4). 776–776. 1 indexed citations

Li, Yiming, Zhi‐Nan Chen, Tianjiao Zhang, et al.. (2024). Id2 epigenetically controls CD8+ T-cell exhaustion by disrupting the assembly of the Tcf3-LSD1 complex. Cellular and Molecular Immunology. 21(3). 292–308. 18 indexed citations

Ma, Hao, Shuaishuai Niu, Shaorong Wang, et al.. (2023). Structure Optimization of 12β-O-γ-Glutamyl Oleanolic Acid Derivatives Resulting in Potent FXR Antagonist/Modulator for NASH Therapy. Pharmaceuticals. 16(5). 758–758. 5 indexed citations

Zhao, Wenbin, Ying Shen, Yiming Li, et al.. (2023). Superantigen-fused T cell engagers for tumor antigen-mediated robust T cell activation and tumor cell killing. Molecular Therapy. 32(2). 490–502. 2 indexed citations

Lin, Jing, Mengen Zhai, Meirui Qian, et al.. (2023). Targeting the up-regulated CNOT3 reverses therapeutic resistance and metastatic progression of EGFR-mutant non-small cell lung cancer. Cell Death Discovery. 9(1). 406–406. 2 indexed citations

10.

Li, Yiming, et al.. (2023). Regulatory Mechanisms and Reversal of CD8+T Cell Exhaustion: A Literature Review. Biology. 12(4). 541–541. 15 indexed citations

11.

Zheng, Ming, Yiming Li, Zhenyu Liu, et al.. (2022). Prognostic Landscape of Tumor-Infiltrating T and B Cells in Human Cancer. Frontiers in Immunology. 12. 731329–731329. 11 indexed citations

12.

Xu, Cong, et al.. (2021). GNA14’s interaction with RACK1 inhibits hepatocellular carcinoma progression through reducing MAPK/JNK and PI3K/AKT signaling pathway. Carcinogenesis. 42(11). 1357–1369. 14 indexed citations

13.

Li, Yiming, Zhenyu Liu, Jianchao Wang, et al.. (2019). Alterations of the Immunologic Co-Stimulator B7 and TNFR Families Correlate with Hepatocellular Carcinoma Prognosis and Metastasis by Inactivating STAT3. International Journal of Molecular Sciences. 20(1). 156–156. 19 indexed citations

14.

Li, Yiming, et al.. (2019). Programmed Death Ligand 1 Indicates Pre-Existing Adaptive Immune Response by Tumor-Infiltrating CD8+ T Cells in Non-Small Cell Lung Cancer. International Journal of Molecular Sciences. 20(20). 5138–5138. 18 indexed citations

15.

Liu, Zhenyu, Ming Zheng, Yiming Li, et al.. (2019). RIP3 promotes colitis-associated colorectal cancer by controlling tumor cell proliferation and CXCL1-induced immune suppression. Theranostics. 9(12). 3659–3673. 73 indexed citations

16.

Tian, Hongwei, Gang Shi, Qin Wang, et al.. (2016). A novel cancer vaccine with the ability to simultaneously produce anti-PD-1 antibody and GM-CSF in cancer cells and enhance Th1-biased antitumor immunity. Signal Transduction and Targeted Therapy. 1(1). 16025–16025. 43 indexed citations

17.

Ren, Hongtao, Yiming Li, Xi-Jing Wang, et al.. (2016). PD-1 rs2227982 Polymorphism Is Associated With the Decreased Risk of Breast Cancer in Northwest Chinese Women. Medicine. 95(21). e3760–e3760. 44 indexed citations

18.

Ma, Yifei, Wei Xu, Yiming Li, et al.. (2016). Patient-oncologist alliance and psychosocial well-being in Chinese society strongly affect cancer management adherence with cancer of unknown primary. Psycho-Oncology. 26(7). 991–998. 3 indexed citations

19.

Li, Junhui, Rui He, Yiming Li, et al.. (2014). Endoscopic Ultrasonography for Tumor Node Staging and Vascular Invasion in Pancreatic Cancer: A Meta-Analysis. Digestive Surgery. 31(4-5). 297–305. 40 indexed citations

20.

Gao, Wen‐Yun, Yiming Li, & Da‐Yuan Zhu. (1999). New Anthraquinones from the Sprout of Crocus sativus. Journal of Integrative Plant Biology. 41(5). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact